Griseofulvin
Back to searchMolecule Structure
Scientific Name
Griseofulvin
Description of the Drug
Griseofulvin is an antifungal agent used to treat a variety of superficial tinea infections and fungal infections of the fingernails and toes.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00400
http://www.drugbank.ca/drugs/DB00400
Brand Name(s)
Fulcin, Fulcin 125, Fulcin 500, Fulsovin, Fulvicin, Fulvicin-p/g, Fulvicin p/g, Fulvicin p/g 165, Fulvicin p/g 330, Fulvicin-u/f, Grifulvin, Grifulvin v, Grisactin, Grisactin ultra, Griseofulvin, Griseofulvin,ultramicrosize, Griseofulvin, ultramicrosize, Grisol af, Gris-peg, Grivate, Ultragris-165, Ultragris-330
Company Owner(s)
Johnson And Johnson Consumer Products Inc, Cipla Ltd, Wyeth Ayerst Laboratories, Pliva Inc, Sigmapharm Laboratories Llc, Sandoz Inc, Valeant Pharmaceuticals Luxembourg Sarl, Chartwell Rx Sciences Llc, Actavis Mid Atlantic Llc, Johnson And Johnson Consumer Companies Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Tubulin | PROTEIN COMPLEX GROUP | INHIBITOR | CHEMBL2364703 |
Clinical Trial(s)
Unichem Links
| Atlas | griseofulvin | ||||
| SureChEMBL | SCHEMBL21988 | ||||
| PharmGKB | PA449814 | ||||
| Human Metabolome Database | HMDB0014544 | ||||
| DrugBank | DB00400 | ||||
| PubChem: Thomson Pharma | 15026839 | 14778634 | |||
| PubChem | 441140 | ||||
| Mcule | MCULE-1983595404 | MCULE-8909987576 | |||
| NMRShiftDB | 60027500 | ||||
| LINCS | LSM-5259 | ||||
| Nikkaji | J4.418K | ||||
| BindingDB | 31775 | ||||
| EPA CompTox Dashboard | DTXSID8020674 | ||||
| LipidMaps | LMPK13060001 | ||||
| DrugCentral | 1331 | ||||
| Metabolights | MTBLC27779 | ||||
| ChemicalBook | CB1766075 | ||||
| rxnorm | GRISEOFULVIN | GRIFULVIN V | GRISEOFULVIN MICROSIZE | GRIS-PEG | GRISEOFULVIN, ULTRAMICROCRYSTALLINE |
| KEGG Ligand | C06686 | ||||
| ChEBI | 27779 | ||||
| ZINC | ZINC000000622123 |
